Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses ————— — Research & development ————— — Operating income 145 M1.13 B1.7 B1.13 B620 M 4.58 B Non-Operating Income, Total 206 M753 M1.14 B280 M236 M 2.41 B Interest expense, net of interest capitalized 13 M14 M13 M13 M13 M 53 M Non-Operating Income, excl. Interest Expenses 193 M739 M1.13 B267 M223 M 2.36 B Unusual income/expense ————— — Pretax income -128 M855 M1.41 B840 M326 M 3.43 B Equity in earnings ————— — Taxes -38 M170 M291 M164 M52 M 677 M Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations -90 M685 M1.12 B676 M274 M 2.76 B Discontinued operations ————— — Net income -90 M685 M1.12 B676 M274 M 2.76 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -90 M685 M1.12 B676 M274 M 2.76 B Basic earnings per share (Basic EPS) -0.574.387.194.321.77 17.66 Diluted earnings per share (Diluted EPS) -0.574.347.114.291.75 17.49 Average basic shares outstanding 156.4 M156.3 M156.1 M156.1 M155.3 M — Diluted shares outstanding 156.4 M157.8 M157.8 M157.7 M157 M — EBITDA 587 M1.58 B2.18 B1.61 B1.1 B 6.47 B EBIT 145 M1.13 B1.7 B1.13 B620 M 4.58 B Cost of revenue 2.41 B2.11 B2.02 B1.95 B2.23 B 8.31 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 442 M453 M476 M480 M483 M 1.89 B